12:00:44 EDT Wed 21 Oct 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:ODT - ODONATE THERAPEUTICS INC - Website unknown - click to update12:00:44 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ODT - Q0.415.76·16.093.415.9786+0.29861.996.31,5271,01915.98  16.14  15.5346.4999  12.5611:42:54Oct 1715 min RT 2¢

Recent Trades - Last 10 of 1019
Time ETExPriceChangeVolume
11:42:54Q15.97860.29861,000
11:42:48Q15.9250.24510
11:42:47Q16.010.336
11:42:35Q15.800.1260
11:42:33Q15.9250.2456
11:42:33Q15.9250.24520
11:42:28Q15.95360.273650
11:42:12Q15.750.078
11:41:44Q15.880.20100
11:41:44Q15.750.07100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-10-17 17:06U:ODTNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline - ODT
2020-10-12 17:00U:ODTNews ReleaseROSEN, A LEADING LAW FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ODT
2020-10-05 16:57U:ODTNews ReleaseROSEN, TRUSTED AND LEADING INVESTOR COUNSEL, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ODT
2020-10-05 08:30U:ODTNews ReleaseResults of CONTESSA, a Phase 3 Study of Tesetaxel in the Treatment of Patients with Metastatic Breast Cancer, to Be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
2020-10-03 19:10U:ODTNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ODT
2020-10-01 00:04U:ODTNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline - ODT
2020-09-30 10:00U:ODTNews ReleaseODT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Odonate Therapeutics, Inc. Shareholders With Losses Exceeding $50K of Class Action and Encourages Shareholders to Contact the Firm
2020-09-27 00:34U:ODTNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline – ODT
2020-09-25 15:53U:ODTNews ReleaseROSEN, A LEADING LAW FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important November 16 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ODT